《糖尿病治療》是一本國(guó)際性的、開放獲取的、同行評(píng)議的、快速出版的雜志(同行評(píng)議在2周內(nèi)完成，發(fā)表后3-4周即被接受)。該雜志致力于出版高質(zhì)量的臨床(所有階段)，觀察，現(xiàn)實(shí)世界和健康結(jié)果的研究圍繞糖尿病治療的發(fā)現(xiàn)，發(fā)展和使用。還鼓勵(lì)開展與診斷、設(shè)備和糖尿病技術(shù)、藥物經(jīng)濟(jì)學(xué)、公共衛(wèi)生和流行病學(xué)、生活質(zhì)量、病人護(hù)理、管理和教育有關(guān)的研究。該雜志對(duì)廣大醫(yī)藥和保健專業(yè)人士感興趣，并發(fā)表原創(chuàng)研究、評(píng)論、病例報(bào)告和簡(jiǎn)短溝通。該雜志面向全球讀者，并收到來(lái)自世界各地的投稿。發(fā)表在《糖尿病治療》雜志上的文章可能伴有分層總結(jié)，以幫助患者(和護(hù)理人員)了解重要的醫(yī)學(xué)進(jìn)展。

Diabetes Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of diabetes therapies. Studies relating to diagnosis, devices and diabetes technology, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world. Articles published in Diabetes Therapy may be accompanied by lay-level summaries, to assist patients (and caregivers) in understanding important medical advances.